IQI
BIIB icon

Integrated Quantitative Investments’s Biogen BIIB Stock Holding History

Integrated Quantitative Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,820
Closed -$354K – 358
2025
Q2 		$354K Buy
2,820
+220
+8% +$27.4K 0.1% 278
2025
Q1 		$356K Sell
2,600
-60
-2% -$8.58K 0.18% 172
2024
Q4 		$407K Buy
+2,660
New +$449K 0.2% 145

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Integrated Quantitative Investments's BIIB Position: Q3 2025 in Review

Integrated Quantitative Investments sold out of Biogen (BIIB) in Q3 2025, closing a stake of 2,820 shares — an estimated $354K sold.

Integrated Quantitative Investments first reported a position in BIIB in Q4 2024 and held it in 3 quarters. The position peaked at $407K in Q4 2024. 908 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Integrated Quantitative Investments reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 2,820 Biogen shares in Q3 2025, an estimated $354K.
  • Integrated Quantitative Investments first reported a position in Biogen in Q4 2024 and held it in 3 quarters.
  • Integrated Quantitative Investments's Biogen position peaked at $407K in Q4 2024.
  • 908 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Integrated Quantitative Investments's 13F filing for Q3 2025, filed 12 Nov 2025.